The role of diagnostic technologies to measure progress toward WHO 2030 targets for soil-transmitted helminth control programs.

by Lieven J Stuyver, Bruno Levecke
Published 2021-06-01

Identification of three immunodominant motifs with atypical isotype profile scattered over the Onchocerca volvulus proteome.

by Ole Lagatie, Bieke Van Dorst, Lieven J Stuyver
Published 2017-01-01

Quasispecies analysis of JC virus DNA present in urine of healthy subjects.

by Tom Van Loy, Kim Thys, Luc Tritsmans, Lieven J Stuyver
Published 2013-01-01

Assessment of multiplex Onchocerca volvulus peptide ELISA in non-endemic tropical regions

by Ole Lagatie, Elodie Granjon, Maurice R. Odiere, Maan Zrein, Lieven J. Stuyver
Published 2019-11-01

2-methyl butyramide, a previously identified urine biomarker for Ascaris lumbricoides, is not present in infected Indonesian individuals

by Ole Lagatie, Emmanuel Njumbe Ediage, Jeroen A. Pikkemaat, Yenny Djuardi, Lieven J. Stuyver
Published 2017-12-01

Identification of antigenic linear peptides in the soil-transmitted helminth and Schistosoma mansoni proteome.

by Johnny Vlaminck, Ole Lagatie, Daniel Dana, Zeleke Mekonnen, Peter Geldhof, Bruno Levecke, Lieven J Stuyver
Published 2021-04-01

Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvM...

by Johnny Vlaminck, Ole Lagatie, Ann Verheyen, Daniel Dana, Bieke Van Dorst, Zeleke Mekonnen, Bruno Levecke, Lieven J. Stuyver
Published 2019-01-01

The HIV-1 integrase mutations Y143C/R are an alternative pathway for resistance to Raltegravir and impact the enzyme functions.

by Sandrine Reigadas, Guerric Anies, Bernard Masquelier, Christina Calmels, Lieven J Stuyver, Vincent Parissi, Herve Fleury, Marie-Line Andreola
Published 2010-01-01

Detection of Ascaris lumbricoides infection by ABA-1 coproantigen ELISA.

by Ole Lagatie, Ann Verheyen, Kim Van Hoof, Dax Lauwers, Maurice R Odiere, Johnny Vlaminck, Bruno Levecke, Lieven J Stuyver
Published 2020-10-01

A synthetic HIV-1 subtype C backbone generates comparable PR and RT resistance profiles to a subtype B backbone in a recombinant virus assay.

by David Nauwelaers, Margriet Van Houtte, Bart Winters, Kim Steegen, Kurt Van Baelen, Ellen Chi, Mimi Zhou, Derek Steiner, Rachelle Bonesteel, Colin Aston, Lieven J Stuyver
Published 2011-01-01

HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.

by Michelle Bronze, Kim Steegen, Carole L Wallis, Hans De Wolf, Maria A Papathanasopoulos, Margriet Van Houtte, Wendy S Stevens, Tobias Rinke de Wit, Lieven J Stuyver, ART-A Consortium
Published 2012-01-01

Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

by Anna Maria Geretti, Zoe Fox, Jeffrey A Johnson, Clare Booth, Jonathan Lipscomb, Lieven J Stuyver, Gilda Tachedjian, John Baxter, Giota Touloumi, Clara Lehmann, Andrew Owen, Andrew Phillips, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
Published 2013-01-01

2-Methyl-pentanoyl-carnitine (2-MPC): a urine biomarker for patent Ascaris lumbricoides infection

by Ole Lagatie, Ann Verheyen, Stijn Van Asten, Maurice R. Odiere, Yenny Djuardi, Bruno Levecke, Johnny Vlaminck, Zeleke Mekonnen, Daniel Dana, Ruben T’Kindt, Koen Sandra, Rianne van Outersterp, Jos Oomens, Ronghui Lin, Lieve Dillen, Rob Vreeken, Filip Cuyckens, Lieven J. Stuyver
Published 2020-09-01